Skip to main content
. 2021 Sep 20;71(8):1567–1576. doi: 10.1136/gutjnl-2021-325181

Figure 4.

Figure 4

Box plots of EQ-5D (A), (B) and IBS-SSS (C) at screening and 2, 6 and 12 months after initiating dietary treatment (GFD) in patients with (grey) or without (white) any CLE reaction to food antigens. CLE, confocal laser endomicroscopy; EQ-5D, European Quality of Life 5 Dimensions; GFD, gluten-free diet; IBS-SSS, irritable bowel syndrome-Symptom Severity Scale; QoL, quality of life; VAS, visual analogue scale.